In this issue:
18F-piflufolastat to diagnose prostate cancer
Four-year results of screening for prostate cancer with PSA and MRI
Prostate virtual high-dose-rate brachytherapy boost
PSCA-CAR T-cell therapy for mCRPC
177Lu-PSMA-617 for progressive mCRPC
Intestinal microbiota prediction of radiotherapy-induced acute GI toxicity
Long-term outcomes using protocol-directed AS
Nomogram to re-define disease stage and risk
Artificial intelligence vs radiologists for MRI prostate cancer detection
High-dose vitamin D to attenuate ADT-induced bone loss
Please login below to download this issue (PDF)